ALX ONCOLOGY HLDGS INC's ticker is ALXO and the CUSIP is 00166B105. A total of 104 filers reported holding ALX ONCOLOGY HLDGS INC in Q2 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $769,920 | -41.2% | 160,400 | -8.0% | 0.00% | – |
Q2 2023 | $1,309,992 | +548013.8% | 174,433 | +229.7% | 0.00% | – |
Q1 2023 | $239 | -75.8% | 52,906 | -39.5% | 0.00% | -100.0% |
Q4 2022 | $986 | -100.0% | 87,446 | -62.3% | 0.00% | 0.0% |
Q3 2022 | $2,222,000 | -36.0% | 232,162 | -45.9% | 0.00% | -50.0% |
Q2 2022 | $3,473,000 | +504.0% | 429,280 | +1161.4% | 0.00% | – |
Q1 2022 | $575,000 | -81.1% | 34,032 | -76.0% | 0.00% | -100.0% |
Q4 2021 | $3,046,000 | +355.3% | 141,718 | +1058.8% | 0.00% | – |
Q2 2021 | $669,000 | +0.8% | 12,230 | +35.9% | 0.00% | – |
Q1 2021 | $664,000 | – | 9,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
venBio Partners LLC | 9,699,925 | $530,392,000 | 62.60% |
Logos Global Management LP | 3,156,981 | $172,624,000 | 14.51% |
Vivo Capital, LLC | 4,220,048 | $230,752,000 | 9.99% |
Foresite Capital Management V, LLC | 231,200 | $12,642,000 | 4.97% |
Cormorant Asset Management, LP | 889,454 | $48,635,000 | 1.65% |
Board of Trustees of The Leland Stanford Junior University | 259,982 | $14,216,000 | 1.33% |
Redmile Group, LLC | 914,035 | $49,979,000 | 0.74% |
SPHERA FUNDS MANAGEMENT LTD. | 192,728 | $10,538,000 | 0.71% |
Financial Advisory Group | 54,041 | $2,955,000 | 0.71% |
Nan Fung Group Holdings Ltd | 34,950 | $1,911,000 | 0.59% |